DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
GWP42006 is an investigational drug.
There have been 4 clinical trials for GWP42006. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2019.
The most common disease conditions in clinical trials are Seizures, Child Development Disorders, Pervasive, and Autistic Disorder. The leading clinical trial sponsors are GW Research Ltd and [disabled in preview].
There are twenty-nine US patents protecting this investigational drug and one hundred and forty-eight international patents.
Recent Clinical Trials for GWP42006
|Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder||GW Research Ltd||Phase 2|
|A Study of GWP42006 in People With Focal Seizures - Part B||GW Research Ltd||Phase 2|
|A Study of GWP42006 in People With Focal Seizures - Part A||GW Research Ltd||Phase 2|
Top disease conditions for GWP42006
Top clinical trial sponsors for GWP42006
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|GWP42006||Start Trial||Enhanced smokable therapeutic cannabis product and method for making same||CMG PARTNERS, INC. (San Jose, CA)||Start Trial|
|GWP42006||Start Trial||Cannabis-based therapeutic product for treatment of chronic pain||CMG PARTNERS, INC. (San Jose, CA)||Start Trial|
|GWP42006||Start Trial||Cannabinoid composition and products including .alpha.-tocopherol||Constance Therapeutics, Inc. (San Francisco, CA)||Start Trial|
|GWP42006||Start Trial||Food and beverage compositions infused with lipophilic active agents and methods of use thereof||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|GWP42006||World Intellectual Property Organization (WIPO)||2018226899||2037-06-06||Start Trial|
|GWP42006||World Intellectual Property Organization (WIPO)||2018227017||2037-06-06||Start Trial|
|GWP42006||World Intellectual Property Organization (WIPO)||2019173242||2037-06-06||Start Trial|
|GWP42006||World Intellectual Property Organization (WIPO)||2019178088||2037-06-06||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|